Prostate Ca assay appears similarly predictive of adverse pathology in African American, Caucasian patients

In this video, Eric Klein, MD, of Glickman Urological and Kidney Institute at Cleveland Clinic discusses a study he presented at the 2020 American Urological Association Virtual Experience. The study evaluated the 17-gene Oncotype DX Genomic Prostate Score assay in African American and Caucasian American men.